Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC114/rtv in HIV-1 Infected Subjects
NCT02187107Phase 2Completed
- Sponsor
- Tibotec
- Start
- Jan 2005
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Jan 2005; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02187107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187107.